Glycogen synthase kinase 3 beta (GSK-3b) plays an important role in neurological outcomes after brain injury. However, its roles and mechanisms in hypoxia-ischemia (HI) are unclear. Activation of mTOR complex 1 (mTORC1) has been proven to induce the synthesis of proteins associated with regeneration. We hypothesized that GSK-3b inhibition could activate the mTORC1 signaling pathway, which may reduce axonal injury and induce synaptic protein synthesis and functional recovery of synapses after HI. By analyzing a P7 rat model of cerebral HI and an in vitro ischemic (oxygen glucose deprivation) model, we found that GSK-3b inhibitors (GSK-3b siRNA or lithium chloride) activated mTORC1 signaling, leading to increased expression of synaptic proteins, including synapsin 1, PSD95, and GluR1, and the microtubule-associated protein Tau and decreased expression of the axonal injury-associated protein amyloid precursor protein. These changes contributed to attenuated axonal injury (decreased amyloid precursor protein staining and axonal loss by silver staining), improved electrophysiological properties of synapses, and enhanced spatial memory performance in the Morris water maze. However, inhibition of mTORC1 by rapamycin blocked the benefits induced by GSK-3b inhibition, suggesting that GSK-3b inhibition induces synaptogenesis and axonal repair via mTORC1 signaling, which may benefit neonatal rats subjected to HI.
INTRODUCTION
Despite the recent progress in hypothermia interventions, hypoxic-ischemic encephalopathy remains one of the leading causes of disability after live birth and results in a substantial economic burden (1) . Axonal injury is not only a characteristic event of a variety of neurological disorders but also a common outcome of multiple neurological diseases (2) . Hypoxia-ischemia (HI) can induce axonal injury and inhibit neurite growth and differentiation, which are important causes of HI neurological sequelae (3, 4) . It is widely accepted that axonal injury may be an early event in neuronal death, and the promotion of axonal regeneration may prevent subsequent neuronal death (5) .
Glycogen synthase kinase 3 beta (GSK-3b), a serine/ threonine kinase, plays an important role in neurological outcomes after HI (6) . GSK-3b can be detected throughout development, from embryos to adult brains (7) . It is widely and highly expressed in brain regions including the cortex, hippocampus, and cerebellum (6) . GSK-3b inhibition by lithium chloride (LiCl) plays a protective role by reducing inflammation and inducing neurogenesis (8, 9) , leading to inhibited neuronal apoptosis and death and decreased infarct volume (10) (11) (12) . Our previous study found that GSK-3b activation was associated with axonal injury in neonatal rat brains after HI (4) . In addition, antidepressant research has shown that a GSK-3b inhibitor can potentiate synaptogenic effects (13) . However, the signaling mechanisms of GSK-3b inhibition in the neonatal rat brain after HI remain unclear.
The mTOR signaling pathway couples cell growth and proliferation with nutrient availability and metabolic cues (14) . Its activity depends on 2 distinct complexes, designated mTOR complex 1 (mTORC1) and complex 2 (mTORC2). mTORC1, but not mTORC2, is sensitive to inhibition by rapamycin. mTORC1 can promote protein synthesis by phosphorylating p70 ribosomal S6 kinase 1 (p70S6K) and eukaryotic initiation factor 4E-binding protein 1 (4EBP1) (15) . Our previous study demonstrated that mTORC1 can regulate neuronal apoptosis after HI (16) . Activation of the mTORC1 pathway can also induce synaptic protein synthesis in rats (17) . Interestingly, GSK-3b inhibitors upregulated mTOR signaling and rescued synaptic plasticity in a mouse model of Alzheimer's disease (18) . Thus, we hypothesized that a GSK-3b inhibitor could activate the mTORC1 signaling pathway in neonatal rat brains exposed to HI, which may reduce axonal injury and induce synaptic protein synthesis and functional recovery of synapses after HI (see Supplementary Data Graphical Abstract and Highlights).
MATERIALS AND METHODS

Experimental Procedures
Animal Protocols
All animal research was approved by the Sichuan University Committee on Animal Research. Postnatal day 7 pups were acquired from the animal center of Sichuan University. The HI model was induced using a method described previously (4) . After anesthetization with halothane, the left common carotid artery of the pups was isolated and permanently double-ligated with a 7-0 silk suture. After recovering from anesthesia for 1 hour, the pups were subjected to 2.5 hours of hypoxia (8% O 2 /92% N 2 ) to produce HI injury. The sham control rats were only subjected to isolation and ligation of the vessels, without occlusion and subsequent ischemia. At the indicated times, the rats were anesthetized and killed for tissue collection. A total of 399 rat pups were used, 23 of which died while in the hypoxia chamber and were not included in the study.
Primary Cortical Cultures and Oxygen Glucose Deprivation
We prepared cortical cultures from E18 rat embryos as previously described (19) . To induce oxygen glucose deprivation (OGD), cultured cells were gently washed twice with phosphate-buffered saline (PBS) and then placed in Dulbecco's Modified Eagle Medium without glucose. The cells were exposed to hypoxia (95% N 2 /5% CO 2 ) at 37 C in an airtight chamber for 3 hours. After 3 hours of OGD treatment, the cell culture medium was changed back to normal NB medium, and the cells were then returned to a 5% CO 2 , 37 C incubator.
Experimental Design
Experiment I
GSK-3b/mTORC1 and downstream proteins, including synaptic proteins (the presynaptic protein synapsin 1 and postsynaptic proteins PSD95 and GluR1), the axonal injuryrelated protein amyloid precursor protein (APP) and the microtubule-associated protein Tau were detected using Western blot. Brain cortices were removed from animals killed at 0.5, 6, 24, and 48 hours after HI (n ¼ 8 per group) according to a previous study (4) (Fig. 1A) .
Experiment II
A GSK-3b inhibitor (GSK-3b siRNA or LiCl) and an mTORC1 inhibitor (rapamycin) were used. The rats were divided into 5 groups: sham, HI, HI þ GSK-3b siRNA, HI þ GSK-3b siRNA þ rapamycin, and HI þ rapamycin (Fig. 1B) ; or sham, OGD, OGD þ LiCl, OGD þ LiCl þ rapamycin, and OGD þ rapamycin (Fig. 1C) ; or sham, HI, HI þ LiCl, HI þ LiCl þ rapamycin, and HI þ rapamycin (Fig. 1D ) (n ¼ 8 per group). At 24 hours after HI, Western blot, immunofluorescence assays, and electrophysiological recordings of miniature excitatory postsynaptic currents (mEPSCs) were performed. At 72 hours after HI, hematoxylin and eosin (H&E), APP, and silver staining were performed (4). At 2 months after HI, the rats performed the Morris water maze (MWM) task for cognitive improvement evaluation (20, 21) .
Drug Administration
Pups received intracerebroventricular injections of a 2-lL solution containing a GSK-3b siRNA lentivirus or a negative control lentivirus (GeneChem, Shanghai, China) 48 hours before HI (Fig. 1B) . The location of each injection was 2 mm rostral and 1.5 mm lateral to the bregma and 2.5 mm beneath the skull surface (4, 22) .
LiCl (Sigma-Aldrich, Carlsbad, CA) was dissolved in sterile water for a dose of 200 mg/kg and administered by oral gavage (PO) to pups 8 hours before HI, while the control group was administered NaCl (200 mg/kg) dissolved in sterile water ( Fig. 1D) (23) .
For the rapamycin-treated group, pups received intraperitoneal (IP) injections of 2 mg/kg rapamycin (Calbiochem, Darmstadt, Germany) 1 hour before HI to inhibit mTOR, while the control group was injected with DMSO ( Fig. 1B, D) (16) .
As a control, the sham and HI groups in Experiment II were given intracerebroventricular injections of negative control lentivirus or PO administration of NaCl (200 mg/kg) and IP injections of DMSO (Fig. 1B, D) .
For the in vitro OGD model, cells were pretreated with LiCl (1 mM) (24) and/or rapamycin (10 nM) (25) or vehicle 24 hours prior to normoxia or OGD exposure. The neurons were then harvested for use in immunofluorescence analysis (Fig. 1C) .
Western Blot Analysis
The cortex was isolated from the left hemisphere. Western blot analysis was performed as previously described (4) . Briefly, equal amounts of total protein (60 lg) from the ipsilateral cortex were separated using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluoride membranes ([PVDF], Roche, Basel, Switzerland). The membranes were blocked and incubated overnight with the following primary antibodies: anti-GSK-3b (Cell Signaling, Danvers, MA, 1:1000); anti-phospho-(p-)GSK-3b (Ser9; Cell Signaling, 1:1000); anti-mTOR (Cell Signaling, 1:1000); anti-p-mTOR (Ser2448; Sigma, 1:1000); anti-p70S6K (Cell Signaling, 1:1000); anti-p-p70S6K (Thr389; Cell Signaling, 1:1000); anti-S6K (Cell Signaling, 1:1000); anti-p-S6K (Ser235/236; Cell Signaling, 1:1000); anti-4E-BP1 (Cell Signaling, 1:1000); anti-p-4E-BP1 (Thr37/46; Cell Signaling, 1:1000); anti-APP (Millipore, Temecula, CA, 1:1000); anti-Tau (Millipore, 1:1000); anti-p-Tau (Ser396; Abcam, 1:500); anti-Synapsin I (Novus Biologicals, Littleton, CO, 1:1000); anti-PSD95 (Cell Signaling, 1:1000); anti-GluR1 (Abcam, 1:1000); and anti-GAPDH (Cell Signaling, 1:1000). The membranes were washed and incubated with secondary antibodies (1:3000, Zen BioScience, Research Triangle Park, NC). The bands were developed using enhanced chemiluminescence (Millipore). NIH ImageJ software was used to measure the densities of the protein signals.
Hematoxylin and Eosin, APP, and Silver Staining
Because both GSK-3b inhibitors had similar effects in our study, only LiCl was used in the following experiments. The pups from the sham, HI, HI þ LiCl, HI þ LiCl þrapamy-cin, and HI þ rapamycin groups were killed 72 hours after HI. Under diethyl ether anesthesia, the pups (n ¼ 8 per group) were perfused transcardially with PBS, followed by 4% paraformaldehyde in 0.1 M PBS. Then, the brains were embedded in paraffin for H&E staining, APP immunohistochemistry, or silver impregnation. For quantitative measurements of axonal injury (APP staining) and loss (silver impregnation), a series of 5-lm-thick sections were cut from 1.0 to 5.0 mm posterior to the bregma. Every tenth coronal section for a total of 5 sections from each brain sample was used for staining. The slides containing the cortex and hippocampus were digitized under 200Â magnification. The data were analyzed in a blinded manner. The data collected from 5 sections were averaged to obtain a single value for 1 animal and were presented as the percentage of positive area for APP and Bielschowsky silver-immunoreactive cells via Image-pro Plus 6.0 (26).
Fluorescence Immunolabeling
For in vivo experiments, the animals were anesthetized and killed 24 hours after HI. Brain tissues were fixed in a 4% paraformaldehyde solution in phosphate buffer for 24 hours at 4 C and then embedded in 3% agarose. The brains were consistently sectioned (40-lm coronal sections) from 1.0 to 5.0 mm posterior to the bregma. The sections were treated The animals were divided into sham, HI, HI þ GSK-3b siRNA, HI þ GSK-3b siRNA þ rapamycin groups, and HI þ rapamycin groups. At 24 hours after HI, WB analysis was performed to evaluate the effects of GSK-3b siRNA on the expression of GSK-3b/mTORC1 and downstream proteins in the brains of rats subjected to HI. As a control, the sham and HI groups were administered intracerebroventricular injections of negative control lentivirus and intraperitoneal (IP) injections of DMSO (n ¼ 8 per group). (C) Neurons were divided into 5 groups: sham, OGD, OGD þ LiCl, OGD þ LiCl þ rapamycin, and OGD þ rapamycin. At 24 hours after OGD, immunofluorescence assays (IF) were performed. (D) The animals were divided into sham, HI, HI þ LiCl, HI þ LiCl þ rapamycin, and HI þ rapamycin groups. At different time points, experiments were performed to evaluate the effects of LiCl in the brains of rats subjected to HI. As a control, the sham and HI groups were PO administrations of NaCl (200 mg/kg) and IP injections of DMSO. At 24 hours after HI, WB analysis, IF assays, and electrophysiological recordings of miniature excitatory postsynaptic currents (mEPSCs) were performed. At 72 hours after HI, H&E, APP, and silver staining were performed. At 2 months after HI, rats performed the Morris water maze (MWM) task to determine cognitive improvement. (n ¼ 8 per group).
with 0.3% (vol/vol) Triton X-100, blocked with 10% (vol/vol) serum, incubated with antibodies against p-S6K (Ser235/236; Cell Signaling, 1:100), and then incubated with a 1:80 dilution of a TRITC-conjugated antirabbit secondary antibody (Sigma).
For in vitro experiments, neurons were fixed in 4% paraformaldehyde for 15 minutes at RT and permeabilized (0.1% Tween-20 in PBS, 5 minutes), and nonspecific binding sites were blocked with PBS/5.0% BSA for 1 hour. The neurons were probed with primary antibodies and incubated overnight at 4 C. The following antibodies were used: anti-p-GSK-3b (Ser9; Cell Signaling, 1:100); anti-p-S6K (Ser235/236; Cell Signaling, 1:100); anti-Synapsin I (Novus Biologicals, 1:100); anti-PSD95 (Cell Signaling, 1:100); and anti-GluR1 (Calbiochem, 1:200). After a washing step (PBS, 5 minutes), the neurons were incubated with secondary antibodies. The nuclei were stained with 4 0 ,6-diamidino-2-phenylindole ([DAPI]), 1:500, Sigma). Images were captured using NIH ImageJ software.
Brain Slice Preparation and Electrophysiological Recordings
Brain slicing was performed as described previously (27) with minor modifications. Briefly, brains were placed in ice-cold (4 C) artificial cerebrospinal fluid (ACSF), in which sucrose (252 mM) was substituted for NaCl (sucrose-ACSF). Coronal slices (400 lm) were cut from a block of tissue containing the prefrontal cortex in sucrose-ACSF with an oscillating-blade tissue slicer. The slices were incubated for 1 hour in oxygenated ACSF at 32 C before recording. All experiments were performed at room temperature (23 6 1 C). The slices were transferred to a recording chamber and continuously perfused with oxygenated ACSF at 2 mL/minute. For whole-cell recordings, pyramidal neurons in layer V were visualized with an upright microscope (BX51-WI, Olympus, Japan) and an infrared video camera (IR1000). The patch pipettes (3-5 MX) were filled with a solution consisting of 140 mM K-gluconate, 4 mM MgCl 2 , 10 mM HEPES, 0.4 mM EGTA, 4 mM MgATP, 0.3 mM Na 2 GTP, and 10 mM phosphocreatine, with the pH adjusted to 7.25 using KOH (290 mOsmol). Tetrodotoxin (TTX, 1 lM) and bicuculline (10 lM) were bath-applied for voltage-clamp recordings of mEPSCs at a holding potential of À70 mV. The data were recorded in gap-free mode and acquired with a 2-kHz Bessel filter at a 10-kHz sampling frequency using a MultiClamp 700B patchclamp amplifier (Molecular Devices, Foster City, CA) and a Digidata 1440 interface (Molecular Devices). The seal resistance was >5 GX, and only data obtained from electrodes with an access resistance <20 MX and <20% change during the recordings were included. Series resistance was compensated automatically during experiments, when necessary. The somatic bridge balance and pipette capacitance were adjusted using MultiClamp 700B Commander software. mEPSCs were analyzed using Mini Analysis (Synaptosoft, Decatur, GA).
Spatial Version of the Morris Water Maze Task
The rats were tested 2 months after HI or sham operation using the MWM task as previously described (20) . A 150-cm circular pool, the sides of which were rendered opaque with nontoxic white paint, was filled with water (25 C). The pool was divided into 4 quadrants. A 10-cm escape platform was fixed in the center of 1 quadrant (the target quadrant) 1-2 cm below the water surface. The activity of animals was monitored by an overhead camera and automatically recorded with Etho Vision 2.3 software. All animals were trained to find the platform daily for 5 days. Each day, the rats performed 4 random trials beginning from 4 different positions. In each trial, the rats swam freely to find the platform within 120 seconds and then stayed on it for 10 seconds. If the rat failed to find the platform, it was placed on the platform for 10 seconds. The time that it took for the animals to find the platform was defined as the escape latency. The mean escape latency to the hidden platform over a 5-day training session was recorded. On the sixth day, the platform was removed. The animals were released at the farthest point from the position of the platform and allowed to swim for 60 seconds. The parameters measured were 1) the mean escape latency of swim over the previous platform location, 2) the percentage of time spent searching the quadrant in which the platform had been submerged during training, and 3) the number of times the rats crossed over the former platform location.
Statistics
Each experiment was performed with 8 samples. The data are represented as the mean 6 standard deviation. The data were quantified in Microsoft Excel 2007 and then exported to GraphPad Prism 5 to create graphs and perform statistical analyses. Significant differences were determined by one-way ANOVA followed by Tukey's test. Cumulative distributions of amplitude for mEPSCs were determined by the Kolmogorov-Smirnov test. A p value <0.05 was considered statistically significant. The individuals who performed image acquisition and data analysis were blinded to the group allocation and the intervention. Electrophysiological recordings were evaluated by Jianghu Zhu, who specializes in neurology. The MWM test was observed by Hongju Chen and Li Zhang, who are experienced in this test.
RESULTS
Expression and Phosphorylation of GSK-3b and mTORC1 After HI After HI was induced, the expression of total GSK-3b, mTOR, p70S6K, S6K, and 4EBP1 remained unchanged ( Fig. 2A and Supplementary Data Fig. S1A ). Transient GSK3b inactivation (increased p-GSK-3b) was observed at 6 hours. However, continuous activation of GSK-3b (decreased p-GSK-3b) was observed at 24 and 48 hours ( Fig. 2A, C) . HI transiently activated the mTORC1 signaling pathway in the prefrontal cortex of rats, as observed by increased levels of the phosphorylated and activated forms of mTOR, p70S6K, S6K, and 4EBP1. However, the levels of phosphorylated mTOR, p70S6K, S6K, and 4EBP1 peaked at 6 hours after HI and were decreased at 24 hours compared with the peak levels, and the levels of phosphorylated proteins at 48 hours were lower in the HI animals than in the sham control animals ( Fig. 2A, C) .
Expression and Phosphorylation of Axonal Injury-Related Proteins and Synaptic Proteins After HI
To further explore HI-induced axonal injury, we measured APP expression and found that it increased gradually and peaked at 48 hours after HI (Fig. 2B, D) . HI also decreased the expression of total Tau (Fig. 2B, D) and induced Tau phosphorylation (Supplementary Data Fig. S1D ) compared with sham controls. Local protein synthesis in synapses is required for the formation, maturation, and function of new spine synapses (17) . We analyzed the levels of several synaptic proteins in the cortex and found that HI decreased the levels of synapsin 1, PSD95, and GluR1 compared with levels in the sham controls (Fig. 2B, D) .
Inhibition of GSK-3b Rapidly Activates mTORC1, Increases Synaptic Protein Expression, and Reduces Axonal Injury After HI To further determine whether GSK-3b is involved in the regulation of mTORC1 and downstream proteins after HI, a GSK-3b-specific siRNA and the chemical GSK-3b inhibitor LiCl were used in this study. We found that total GSK-3b, mTOR, p70S6K, S6K and 4EBP1 expression remained GSK-3b/mTORC1: Synaptogenesis and Axonal Repair unchanged, with the exception of the decrease in total GSK-3b expression due to GSK-3b siRNA ( Fig. 3 and Supplementary Data Fig. S1B, C) . Both inhibitors significantly decreased GSK-3b activity, leading to activated mTORC1 signaling. Increased levels of the phosphorylated and activated forms of mTOR, p70S6K, S6K, and 4EBP1 were observed at 24 hours after HI in rats treated with the inhibitors compared with rats exposed to HI alone ( The effect of GSK-3b inhibition on mTORC1 activation was blocked by the selective mTOR inhibitor rapamycin (Figs. 3 and 4 and Supplementary Data Fig. S2A ). Rapamycin also increased the expression of the axonal injury-related protein APP and decreased the expression of Tau and the synaptic proteins PSD95, GluR1, and synapsin I (Fig. 5 and Supplementary Data Fig. S2B-D) . Because of the similar effects of LiCl and GSK-3b siRNA, only LiCl was used in the following experiments.
GSK-3b Inhibition Improves the Electrophysiological Properties of Cortical Synapses
The increased expression of synaptic proteins indicated that GSK-3b inhibition rapidly increases synapse formation. We therefore examined the effect of LiCl on the electrophysiological properties of neurons at 24 hours after HI. mEPSCs frequency and amplitude, which are mediated predominantly by cortical-cortical synapses, were significantly higher in the LiCl group than in the HI group (Fig. 6) , which was consistent with the elevated expression of the synaptic proteinssynapsin 1, PSD95, and GluR1. However, the induction of mEPSCs by LiCl was blocked by rapamycin (Fig. 6 ).
GSK-3b Inhibition Prevents HI-Induced Brain Damage
To elucidate whether GSK-3b inhibition by LiCl could regulate histological injury, conventional H&E staining was performed (Fig. 7A) . Neuronal morphology was normal in the control rats. H&E staining revealed that HI resulted in abnormal neuron morphology, with pyknotic nuclei and enlarged extracellular spaces at 72 hours. LiCl alleviated this injury compared with that in the HI group. Injury to the cortex reoccurred when LiCl was combined with rapamycin, demonstrating that GSK-3b/mTORC1 signaling is involved in HI injury.
To assess whether axonal injury is associated with histological damage, we detected APP expression using immunohistochemistry. The APP-positive area was significantly increased in the HI group compared with sham rats at 72 hours after HI. The APP-positive area was decreased by LiCl pretreatment, whereas mTOR inhibition by rapamycin blocked the protective effects of LiCl (Fig. 7B, D) .
To determine whether the axonal loss is involved in histological damage, we performed Bielschowsky silver impregnation to observe axonal loss. Silver staining showed that axonal loss was significantly increased in HI rats at 72 hours after HI compared with that in the sham controls. LiCl pretreatment significantly increased axon intensity compared with that in the HI group. However, mTOR inhibition by rapamycin blocked the effects of LiCl after HI, indicating that mTOR activation is essential for axonal protection by LiCl (Fig. 7C, D) .
GSK-3b Inhibition Rescues Long-Term Spatial Memory Impairments
The MWM test was performed to determine the longterm effect of LiCl on learning and memory in HI rats at 2 months after HI. A significant difference between the HI and sham groups was observed throughout the entire 5-day training session. LiCl reduced the mean escape latency to the hidden platform as training progressed compared with that in the HI group (Fig. 8A) . The probe test was performed 24 hours after the last training session in the absence of the escape platform. The escape latency to swim over the previous position of the escape platform was longer in the HI group than in the sham group. However, the LiCl group had a noticeably shorter time required to reach the platform location than the HI group (Fig. 8B) . Furthermore, the LiCl-treated rats spent more time swimming in the target quadrant that previously contained the escape platform than the HI group (Fig. 8C) . With respect to the number of times the rats crossed over the former target position, the LiCl group displayed significantly more crossings than the HI animals (Fig. 8D) . No significant differences were observed between the LiCl þ rapamycin and HI animals, suggesting that the selective mTOR inhibitor abolished the rescue effect of LiCl on memory capacity (Fig. 8) .
DISCUSSION
Emerging evidence has shown that GSK-3b inhibition results in various protective effects, including reduced inflammation (28, 29) , apoptosis (30, 31) , and astrogliosis (6), increased angiogenesis (32) and neural stem cell proliferation FIGURE 5. Via mTORC1 activation, GSK-3b inhibition reduced the expression of the axonal injury-related protein APP and increased the expression of the microtubule-associated protein Tau and synaptic proteins (synapsin I, PSD95, and GluR1) after HI. (A) Western blot analysis showed that GSK-3b siRNA reduced the expression of the axonal injury-related protein APP and increased the expression of the microtubule-associated protein Tau and synaptic proteins (synapsin I, PSD95, and GluR1). (B) Western blot analysis showed that LiCl reduced the expression of the axonal injury-related protein APP and increased the expression of the microtubule-associated protein Tau and synaptic proteins (synapsin I, PSD95, and GluR1). (C) Quantitative analysis of the effect of GSK-3b siRNA on APP, Tau, synapsin 1, PSD95, and GluR1 expression levels (n ¼ 8 per group). *p < 0.05, **p < 0.01 vs sham. (D) Quantitative analysis of the effect of LiCl on APP, Tau, synapsin 1, PSD95, and GluR1 expression levels (n ¼ 8 per group). *p < 0.05, **p < 0.01 vs sham. Note: Although GAPDH was used as a loading control for quantification of each individual blot, only some of the loading controls are shown here due to layout limitations.
(32), and maintenance of blood-brain barrier integrity (33) . In the early period of neuron development, GSK-3b activity is negatively associated with axonal development and synaptic plasticity, which is independent of its function during HI. On one hand, GSK-3b inhibition induces axonal development. In rat embryonic neurons, GSK-3b inhibition induces activation of collapsin response mediator protein-2 (CRMP-2) (34), leading to an increased number of axons and decreased number of dendrites. Conversely, increasing GSK-3b activity inhibits axon formation (24) and is associated with the suppression of synaptic plasticity. In developmental neurons, GSK-3b overexpression decreases the density of dendritic spines, hindering the formation of new synaptic contacts (35) .
Neuronal axon regeneration and synaptogenesis are important forms of neural regeneration after HI. Akt/GSK-3b activation was reported to be involved in axon growth and synaptogenesis in a cerebral HI model (36, 37) . Furthermore, GSK-3b upregulation impairs synaptic plasticity both functionally and structurally (38) , while genetic inhibition of GSK-3b increases the number of synapses (39) . However, the precise mechanism by which GSK-3b inhibition affects synaptogenesis and axon regeneration after HI remains unclear. In this study, we found that GSK-3b inhibition is critical for neural regeneration processes, including axon remodeling and synaptogenesis, in neonatal rats with HI-induced brain damage. We demonstrate for the first time that mTORC1-dependent synapse formation and axonal repair underlie the novel protective effects of GSK-3b inhibition. We also provide evidence supporting the involvement of the GSK-3b/ mTORC1 pathway in synapse formation and axonal repair after HI. First, the simultaneous changes in the expression of GSK-3b/mTORC1 pathway-related proteins after HI suggest that GSK-3b might regulate the activity of mTORC1 and downstream proteins in HI-induced brain injury. At 6 hours after HI, transient inactivation of GSK-3b was associated with transient activation of mTORC1 signaling. It is possible that this finding reflects an attempt to repair the brain damage, or it may be due to the activation of Akt, upstream of GSK-3b (4). After 6 hours, continued activation of GSK-3b was accompanied by decreased mTORC1 signaling. This led to decreased expression of synaptic proteins and the microtubuleassociated protein Tau and increased expression of the axonal injury-related protein APP.
Second, supporting our hypothesis, GSK-3b-specific inhibitors (LiCl or GSK-3b siRNA) induced activation of mTORC1 signaling. Recent studies have demonstrated that GSK-3b is an inhibitory molecule that functions upstream of mTOR in a variety of physiological states and disease models, such as in glucose metabolism (40) and in tumors (41) . In the current study, 2 GSK-3b inhibitors upregulated mTOR activity and that of its 2 main substrates, p70S6K and 4EBP1, demonstrating that GSK-3b inhibition could increase mTORC1 activity after HI. It has been demonstrated that the activated mTORC1 pathway induces cell growth by promoting translation, ribosome biogenesis in response to environmental cues (42) . In our study, mTORC1 activation resulted in increased activity of synaptic proteins and the microtubule-associated protein Tau and decreased axonal injury. Furthermore, brain function was improved, as represented by increased mEPSCs frequency and amplitude and increased long-term spatial memory in the MWM task. However, the protective effect of GSK-3b inhibition was abolished by the mTOR inhibitor rapamycin. Therefore, the GSK-3b/mTORC1 pathway might play a critical role in regulating synapse formation and axonal repair after HI in the developing rat brain.
Functional recovery after HI depends on the expression of synaptic proteins. Synapsin 1 is a synaptic protein implicated in neuroplasticity that regulates the proportion of vesicles available for release in the presynaptic terminal. PSD95 and GluR1 are highly abundant synaptic proteins in the postsynaptic density and have been proposed to regulate many aspects of synaptic transmission (43) . We found that the expression of these synaptic proteins decreased after HI, indicating a failure in synaptic functioning. These results are similar to those of a recent study showing downregulation of synaptic proteins after ischemia in adult animals (44) . However, Xu et al (45) offer contradictory findings, showing elevated GluR1 levels in the hippocampus after HI. We speculate that this inconsistency may be due to the different brain regions studied (cortex vs hippocampus).
Synaptic reconstruction after HI relies on significantly increased expression of synaptic proteins, which promotes axonal sprouting and new synapse formation (36) . Notably, mTORC1 activation has been linked with the production of synaptic proteins involved in the formation, maturation, and function of new spine synapses (17) , resulting in increased mEPSCs frequency and amplitude (13) . Here, we found that activation of mTORC1 signaling by GSK-3b inhibition led to increased expression of synaptic proteins (synapsin 1, PSD95, and GluR1), which was concurrent with increases in the frequency and amplitude of mEPSCs. These increases contributed to the improvement of cognitive function in neonatal rats after HI, as shown by improved MWM task performance, whereas rapamycin blocked these effects, indicating that the benefit of GSK-3b inhibition requires activation of mTORC1 signaling.
Neuronal axon regeneration requires microtubule recombination to reconstruct the axonal cytoskeleton and prolong axons. Current axonal regeneration research has focused on microtubule recombination-related mechanisms (46) . GSK-3b acts as a key regulator of microtubule recombination by modulating the expression of microtubule-associated proteins. Our previous study demonstrated that an important microtubule-associated protein, CRMP-2, was inactivated by GSK-3b (4). Tau is the most abundant microtubule-associated protein and promotes microtubule assembly and helps stabilize their structure (47) . Thus, Tau plays an important role in the maintenance of neuronal morphology and the formation of axonal processes and is critically involved in vesicular transport and axonal polarity (48) .
Tau hyperphosphorylation is considered a hallmark of brain injury in a variety of neurodegenerative diseases (49) . Hyperphosphorylated Tau does not bind to or stabilize microtubules, while fully dephosphorylated Tau binds to microtubules with high affinity (48) . Numerous studies have demonstrated that GSK-3b induces Tau hyperphosphorylation after HI (50) (51) (52) (53) (54) . Consistent with this, we also found that HI induced hyperphosphorylation of Tau, which was closely related to GSK-3b activation. Unlike the Tau phosphorylation state, information regarding the role of total Tau protein remains lacking, especially in HI conditions. Cerebral total Tau has been identified as a highly sensitive component of the cytoskeleton and is important in cellular integrity (49) . Hypoxia can alter the gene expression of Tau (55) . Significant degradation of total Tau was reported in an adult rat model of transient global ischemia (56) . In human cerebral ischemic stroke patients, total Tau protein can be detected in serum, indicating neuronal damage (57) . In neonates under HI, the serum total Tau protein level can be used to predict the neurodevelopmental outcome (58) . Thus, we focused on the regulation of total Tau expression in the developing rat brain after HI. We found that HI decreased total Tau expression and induced axonal degeneration in neonatal rats. Tau is an important potential substrate of mTOR. In primary cultured embryonic hippocampal neurons, mTOR activation can increase downstream p70S6K activity and induce mRNA and protein synthesis of Tau, which promotes axonal extension (59) . In our study, GSK-3b inhibition increased Tau expression via upregulation of mTORC1 activity. Attenuation of axonal injury (eg decreased APP expression and axon loss) were also observed upon GSK-3b inhibition, which may be partly because increased Tau expression accelerated microtubule-mediated membrane trafficking and vesicle distribution in axons and facilitated axonal repair after HI.
HI can induce 3 types of cell death, namely, autophagic cell death, necrosis, and apoptosis. Apoptosis has been demonstrated to be the leading type of cell death in postnatal neurons (60) . Our previous study demonstrated that mTORC1 participates in the regulation of neuronal apoptosis, performing a neuroprotective function after HI in the developing rat brain (16) . Therefore, the beneficial effects of GSK-3b inhibition could also be due to the well-known antiapoptotic effect of mTORC1 signaling. Questions have been raised about the relationship between the antiapoptotic and axonal repair effects of GSK-3b inhibition. However, it remains unclear whether one is a cause or a consequence of the other. Most neural proteins are synthesized in the cell body and need to be transported down the axon. Therefore, intracellular transport is crucial for neuronal survival and prevents subsequent neuronal apoptosis (61) . We speculate that axonal repair due to GSK-3b inhibition facilitated axonal transport, creating a better environment for neurons and thereby contributing to the antiapoptotic effects of GSK-3b inhibition.
